These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2496128)

  • 1. Plasminogen activators in the mouse mammary gland. Decreased expression during lactation.
    Busso N; Huarte J; Vassalli JD; Sappino AP; Belin D
    J Biol Chem; 1989 May; 264(13):7455-7. PubMed ID: 2496128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1.
    Casslén B; Sandberg T; Gustavsson B; Willén R; Nilbert M
    Biol Reprod; 1998 Jun; 58(6):1343-50. PubMed ID: 9623591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of somatic cell-associated activation of plasminogen to caseinolysis within the goat mammary gland.
    Weng MH; Chang CJ; Chen WY; Chou WK; Peh HC; Huang MC; Chen MT; Nagahata H
    J Dairy Sci; 2006 Jun; 89(6):2025-37. PubMed ID: 16702266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice.
    Pittius CW; Hennighausen L; Lee E; Westphal H; Nicols E; Vitale J; Gordon K
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5874-8. PubMed ID: 2842753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
    Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
    Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N; Belin D; Failly-Crépin C; Vassalli JD
    Cancer Res; 1987 Jan; 47(2):364-70. PubMed ID: 3098408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist effect of RU 486 on transcription of glucocorticoid-regulated genes.
    Busso N; Collart M; Vassalli JD; Belin D
    Exp Cell Res; 1987 Dec; 173(2):425-30. PubMed ID: 3121370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
    Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo.
    Quax PH; de Bart AC; Schalken JA; Verheijen JH
    Prostate; 1997 Aug; 32(3):196-204. PubMed ID: 9254899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase-type plasminogen activator is increased in the involuting ventral prostate of castrated rats.
    Andreasen PA; Kristensen P; Lund LR; Danø K
    Endocrinology; 1990 May; 126(5):2567-76. PubMed ID: 2109689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines.
    Lyon PB; See WA; Xu Y; Cohen MB
    Prostate; 1995 Oct; 27(4):179-86. PubMed ID: 7479384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia.
    Hayden SM; Seeds NW
    J Neurosci; 1996 Apr; 16(7):2307-17. PubMed ID: 8601810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of transferrin mRNA concentration in the rabbit mammary gland during the pregnancy-lactation-weaning cycle and in cultured mammary cells. A comparison with the other major milk protein mRNAs.
    Puissant C; Bayat-Sarmadi M; Devinoy E; Houdebine LM
    Eur J Endocrinol; 1994 May; 130(5):522-9. PubMed ID: 8180682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.
    Sappino AP; Huarte J; Belin D; Vassalli JD
    J Cell Biol; 1989 Nov; 109(5):2471-9. PubMed ID: 2509486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.
    Baird J; Lazarus GS; Belin D; Vassalli JD; Busso N; Gubler P; Jensen PJ
    J Invest Dermatol; 1990 Nov; 95(5):548-52. PubMed ID: 2121833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J; Alanko T; Lehtonen E; Saksela O
    Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
    Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
    J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.